RETRACTED: Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability (Retracted Article)

被引:31
作者
Cai, Jun [1 ]
Wu, Lin [1 ]
Qi, Xiaoping [1 ]
Shaw, Lynn [2 ]
Calzi, Sergio Li [2 ]
Caballero, Sergio [2 ]
Jiang, Wen G. [3 ]
Vinores, Stanley A. [4 ]
Antonetti, David [5 ]
Ahmed, Asif [6 ]
Grant, Maria B. [2 ]
Boulton, Michael E. [1 ]
机构
[1] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA
[2] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA
[3] Cardiff Univ, Sch Med, Dept Surg, Cardiff, S Glam, Wales
[4] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA
[5] Penn State Coll Med, Hershey, PA USA
[6] Univ Edinburgh, Coll Med & Vet Med, Queens Med Res Inst, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
来源
PLOS ONE | 2011年 / 6卷 / 03期
基金
英国惠康基金; 英国医学研究理事会; 美国国家卫生研究院;
关键词
BLOOD-RETINAL BARRIER; FACTOR RECEPTOR-1; ENDOTHELIAL-CELLS; TIGHT JUNCTIONS; TUMOR-GROWTH; PATHOLOGICAL CONDITIONS; INDUCED ANGIOGENESIS; CADHERIN GENE; CANCER-CELLS; MICE;
D O I
10.1371/journal.pone.0018076
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Increased vascular permeability is an early event characteristic of tissue ischemia and angiogenesis. Although VEGF family members are potent promoters of endothelial permeability the role of placental growth factor (PlGF) is hotly debated. Here we investigated PlGF isoforms 1 and 2 and present in vitro and in vivo evidence that PlGF-1, but not PlGF-2, can inhibit VEGF-induced permeability but only during a critical window post-VEGF exposure. PlGF-1 promotes VE-cadherin expression via the trans-activating Sp1 and Sp3 interaction with the VE-cadherin promoter and subsequently stabilizes transendothelial junctions, but only after activation of endothelial cells by VEGF. PlGF-1 regulates vascular permeability associated with the rapid localization of VE-cadherin to the plasma membrane and dephosphorylation of tyrosine residues that precedes changes observed in claudin 5 tyrosine phosphorylation and membrane localization. The critical window during which PlGF-1 exerts its effect on VEGF-induced permeability highlights the importance of the translational significance of this work in that PLGF-1 likely serves as an endogenous anti-permeability factor whose effectiveness is limited to a precise time point following vascular injury. Clinical approaches that would pattern nature's approach would thus limit treatments to precise intervals following injury and bring attention to use of agents only during therapeutic windows.
引用
收藏
页数:16
相关论文
共 55 条
  • [1] Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
    Autiero, M
    Luttun, A
    Tjwa, M
    Carmeliet, P
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) : 1356 - 1370
  • [2] Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
    Autiero, M
    Waltenberger, J
    Communi, D
    Kranz, A
    Moons, L
    Lambrechts, D
    Kroll, J
    Plaisance, S
    De Mol, M
    Bono, F
    Kliche, S
    Fellbrich, G
    Ballmer-Hofer, K
    Maglione, D
    Mayr-Beyrle, U
    Dewerchin, M
    Dombrowski, S
    Stanimirovic, D
    Van Hummelen, P
    Dehio, C
    Hicklin, DJ
    Persico, G
    Herbert, JM
    Communi, D
    Shibuya, M
    Collen, D
    Conway, EM
    Carmeliet, P
    [J]. NATURE MEDICINE, 2003, 9 (07) : 936 - 943
  • [3] PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth
    Bais, Carlos
    Wu, Xiumin
    Yao, Jenny
    Yang, Suya
    Crawford, Yongping
    McCutcheon, Krista
    Tan, Christine
    Kolumam, Ganesh
    Vernes, Jean-Michel
    Eastham-Anderson, Jeffrey
    Haughney, Peter
    Kowanetz, Marcin
    Hagenbeek, Thijs
    Kasman, Ian
    Reslan, Hani Bou
    Ross, Jed
    Van Bruggen, Nick
    Carano, Richard A. D.
    Meng, Yu-Ju Gloria
    Hongo, Jo-Anne
    Stephan, Jean-Philippe
    Shibuya, Masabumi
    Ferrara, Napoleone
    [J]. CELL, 2010, 141 (01) : 166 - 177
  • [4] Tight junctions at a glance
    Balda, Maria S.
    Matter, Karl
    [J]. JOURNAL OF CELL SCIENCE, 2008, 121 (22) : 3677 - 3682
  • [5] Blockage of VEGF-induced angiogenesis by preventing VEGF secretion
    Björndahl, M
    Cao, RH
    Eriksson, A
    Cao, YH
    [J]. CIRCULATION RESEARCH, 2004, 94 (11) : 1443 - 1450
  • [6] Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS
    Cai, J
    Jiang, WG
    Ahmed, A
    Boulton, M
    [J]. MICROVASCULAR RESEARCH, 2006, 71 (01) : 20 - 31
  • [7] Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1 (Withdrawn Publication. See vol. 298, 2021)
    Cai, J
    Jiang, WG
    Grant, MB
    Boulton, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (06) : 3604 - 3613
  • [8] Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells
    Cai, J
    Ahmad, S
    Jiang, WG
    Huang, JH
    Kontos, CD
    Boulton, M
    Ahmed, A
    [J]. DIABETES, 2003, 52 (12) : 2959 - 2968
  • [9] Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
    Cao, Yihai
    [J]. SCIENCE SIGNALING, 2009, 2 (59) : re1
  • [10] Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
    Carmeliet, P
    Lampugnani, MG
    Moons, L
    Breviario, F
    Compernolle, V
    Bono, F
    Balconi, G
    Spagnuolo, R
    Oosthuyse, B
    Dewerchin, M
    Zanetti, A
    Angellilo, A
    Mattot, V
    Nuyens, D
    Lutgens, E
    Clotman, F
    de Ruiter, MC
    Gittenberger-de Groot, A
    Poelmann, R
    Lupu, F
    Herbert, JM
    Collen, D
    Dejana, E
    [J]. CELL, 1999, 98 (02) : 147 - 157